[{"title": "EFFICACY OF FINERENONE ACCORDING TO LEFT ATRIAL SIZE IN PATIENTS WITH HEART FAILURE AND MILDLY REDUCED OR PRESERVED EJECTION \u2026", "link": "https://www.jacc.org/doi/full/10.1016/S0735-1097%252825%252901679-1", "details": "M Chimura, A Henderson, PS Jhund, B Claggett\u2026 - Journal of the American \u2026, 2025", "abstract": "Background Left atrial (LA) enlargement may reflect elevated LA pressure and be associated with worse outcomes in heart failure and mildly reduced or preserved ejection fraction (HFmrEF/HFpEF). We examined the association between LA size \u2026"}, {"title": "INCREASED LIVER FIBROSIS RISK PREDICTS ADVERSE CARDIOVASCULAR OUTCOMES AND MORTALITY IN HEART FAILURE WITH PRESERVED EJECTION \u2026", "link": "https://www.jacc.org/doi/full/10.1016/S0735-1097%252825%252901656-0", "details": "A KALAYCI, S Siqueira, MR Zile, MA Pfeffer, CSP Lam\u2026 - Journal of the American \u2026, 2025", "abstract": "Background The liver and heart are intricately linked. The Fibrosis-4 (FIB-4) score, initially validated for liver fibrosis, has emerged as a broader indicator of systemic tissue fibrosis. Limited data exist regarding its applicability in heart failure with \u2026"}]
